Building from more than a decade of proven leadership in the wireless connectivity space, Texas Instruments Incorporated (TI) (NASDAQ: TXN) today unveiled the SimpleLink™ product family, the industry’s widest portfolio of easy-to-use wireless connectivity technologies for low-power, low-cost embedded applications. The SimpleLink family includes self-contained wireless processors, aimed at enabling easy integration with any embedded system.
The cornerstone offering in this new family is the new SimpleLink Wi-Fi® CC3000 product: an easy-to-implement Wi-Fi solution that will lead the charge in expanding the world’s Internet of Things. The SimpleLink Wi-Fi CC3000 is a self-contained 802.11 network processor, making it ideal for simple and quick addition of Internet connectivity to any embedded application. For full details on the SimpleLink Wi-Fi CC3000 and all SimpleLink products, visit http://ti.com/simplelink.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54039-texas-instruments-launches-product-family-simplelink-wi-fi-cc3000
http://www.databaserecords.com/business/ - DataBaseRecords.com is a leading on-line records search provider. We provide Business Background Screening Services for families, landlords, companies and employers with confidential, reliable and low-cost statewide criminal search services of numerous types such as our instant statewide criminal record checks. To start your Business Background Screening contact us Today 615-449-8991 or visit us on Facebook. https://www.facebook.com/verifiedsafe
Imagine upgrading from ARM9™-based product designs to add 3D interactive touch screens, higher resolution displays, faster performance and multiple, flexible integrated connectivity options for a more robust offering — all while keeping design costs and power levels low. Visualize taking these new products to market in six months with an inexpensive development platform and free, complete software development kit. Texas Instruments Incorporated (NYSE: TXN) (TI) now makes this design vision a reality with its new Sitara™ AM335x ARM® Cortex™-A8 microprocessors .
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/texasinstruments/51795/
Just as the relaxed pace of summer vacation gives way to the hectic schedule and morning routine of the new school year, Inventure Foods, Inc. (NASDAQ: SNAK) is expanding its successful line of Jamba® All Natural Smoothies with a new tropically inspired “at home” smoothie flavor that’s sure to keep the spirit of summer alive.
Caribbean Passion® combines mango, peaches, strawberry and passion fruit flavors to offer a convenient, better-for-you snack that fits busy back-to-school schedules. Naturally low in fat and just 120 calories or less per serving, Jamba All Natural Smoothies® (www.AtHomeSmoothies.com) contain real fruit and non-fat yogurt that when blended with apple juice produce a genuine Jamba® smoothie in the comfort of your home. The smoothies feature only natural ingredients and they are gluten-free.
To view Multimedia News Release, go to http://www.multivu.com/mnr/50942-inventure-foods-jamba-all-natural-at-home-smoothie-line-expands
Vehicles are doing a better job of protecting people in crashes, but a new crop of advanced technology aims to prevent many crashes from happening altogether. A new study by the Highway Loss Data Institute (HLDI) finds that one kind of advanced forward collision avoidance system is working to prevent about a quarter of the common low-speed crashes that happen in everyday commuter traffic.
The study of insurance claims found that Volvo XC60 midsize SUVs outfitted with a standard collision avoidance feature called City Safety are far less likely to be involved in low-speed crashes than comparable vehicles without the system. City Safety is designed to help a driver avoid rear-ending another vehicle in slow-moving, heavy traffic. Claims under property damage liability coverage — the insurance that pays for damage to vehicles that an at-fault driver hits — were filed 27 percent less often for the XC60 than other midsize luxury SUVs.
For more information: www.iihs.org
When it comes to their health, nearly 90 percent of Americans lack the literacy skills to understand basic medical information and instruction. Low literacy has been linked to poor health outcomes such as higher rates of hospitalization and less frequent use of preventive services. A few quick minutes with a physician is not sufficient for most of us to understand a complex or chronic medical condition and how we can manage it. But new research indicates that video storytelling can be an effective way to educate people about health conditions - and watching others share their health stories can empower people to take control of their own health.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/besmartbewell/50819/
General Dynamics C4 Systems has received an order from the U.S. Department of Defense for the Joint Tactical Radio System (JTRS) Handheld, Manpack, Small Form Fit (HMS) Rifleman radio (AN/PRC-154) and Manpack (AN/PRC-155) radio. Following a recent Milestone C decision, the Low Rate Initial Production (LRIP) order, which has an initial value of approximately $56.4 million, calls for the production of 6,250 Rifleman and 100 Manpack radios and includes expenses for non-recurring startup costs, accessories, training, related equipment and supplies.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51006-jtrs-rifleman-radio-soldier-network
Uncertainty and erratic moves will be the norm rather than the exception reports Saxo Bank, the online trading and investment specialist, in its economic outlook for the third quarter of 2011. The second half of 2011 will be volatile and the uncertainty almost as great as during the financial crisis.
The most probable outlook for Q3 is that the world extends monetary stimulus across the global economies. This will bring marginal higher growth but also increase the burden on fiscal payments and a need for structural changes. Any long-term solution needs to be forward looking and involve an agenda for dragging Europe out of the low growth stalemate. A solution based on buying more time will only take us closer to the feared full blown Crisis 2.0.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/saxobank/50522/
Plantronics, Inc. (NYSE: PLT) is the first headset company to be certified for TCO Certified Headsets 2. The new certification, launched today, is awarded to headsets that are designed for maximum performance, usability and have minimal environmental impact. It builds on the foundations of the existing TCO'07 certification programme with emphasis on sustainability, environmental compliance and corporate social responsibility. Headsets that are TCO Certified are third party tested for low emissions, superior sound quality and high durability.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/tcodevelopment/50511/
Shell and Cosan today launched a multi-billion dollar joint venture that will become a leading producer of the low-carbon biofuel, ethanol made from sugar cane. Named Raízen, this major retail and commercial fuels company will operate in Brazil, one of the world's fastest-growing markets.
In one of the biggest biofuels deals to date, Shell is combining its extensive retail experience, global network and research in advanced biofuels with Cosan's technical knowledge of producing biofuels on a large scale. Raízen will produce and sell over 2 billion litres a year of the lowest-carbon biofuel commercially available - ethanol made from Brazilian sugar cane.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shell/48921/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
From the album ROADSAW on Small Stone Records.
Video by CircumVision Video and Parentheses Productions. Written and directed by Tim Catz and Mike Gill. Shot and Edited by Mike Gill. Feb. 2011
